Medicare Enrolled

Dr. Mark Russo, MD, PHD

Nephrology · Naples, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
878 109TH AVE N, Naples, FL 34108
2395131002
In practice since 2005 (20 years)
NPI: 1316934326 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Russo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Russo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Russo

Dr. Mark Russo is a nephrology in Naples, FL, with 20 years in practice. Based on federal Medicare data, Dr. Russo performed 2,873 Medicare services across 1,494 unique beneficiaries.

Between the years covered by Open Payments, Dr. Russo received a total of $75,386 from 45 pharmaceutical and/or device companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Russo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 18% volume in FL$ $75,386 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,873
Medicare services
Top 18% in FL for nephrology
1,494
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~144 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)972$80$150
Dialysis services, 4 or more physician visits per month (20 years or older)309$293$500
Home dialysis services per month (20 years or older)206$246$450
Dialysis services, 2-3 physician visits per month (20 years or older)173$243$418
Remote patient monitoring management, 20 min/month169$39$100
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes165$32$100
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month163$50$125
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month144$38$100
Remote patient monitoring device, 30 days129$39$100
New patient office visit (45-59 min)101$127$250
Office visit, established patient, complex (40-54 min)82$105$300
Hospital follow-up visit, high complexity78$95$200
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment60$15$50
Hospital follow-up visit, moderate complexity43$65$200
Initial hospital admission, high complexity26$138$250
Dialysis services, 1 physician visit per month (20 years or older)20$166$335
Hemodialysis, single evaluation18$58$150
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional15$16$75
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$75,386
Total received (2018-2024)
Avg $10,769/year across 7 years
Top 3% in FL for nephrology
45
Companies
533
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$61,567 (81.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,749 (15.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,070 (2.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,538
2023
$2,016
2022
$3,662
2021
$2,237
2020
$5,315
2019
$29,622
2018
$28,997

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Relypsa, Inc.
$26,298
Mallinckrodt LLC
$11,344
Novartis Pharmaceuticals Corporation
$10,122
Mallinckrodt Enterprises LLC
$9,512
Mallinckrodt Hospital Products Inc.
$4,422
Baxter Healthcare
$2,347
BAXTER HEALTHCARE
$1,888
Vifor Pharma, Inc.
$1,585
AstraZeneca Pharmaceuticals LP
$857
Bayer HealthCare Pharmaceuticals Inc.
$669
OPKO Pharmaceuticals, LLC
$602
Otsuka America Pharmaceutical, Inc.
$502
Amgen Inc.
$501
Horizon Therapeutics plc
$453
Bayer Healthcare Pharmaceuticals Inc.
$452
GlaxoSmithKline, LLC.
$442
GastroKlenz, Inc. DBA CloudCath
$400
Alnylam Pharmaceuticals Inc.
$351
Travere Therapeutics, Inc.
$345
Aurinia Pharma U.S., Inc.
$241
Daiichi Sankyo Inc.
$193
Kaneka Pharma America LLC
$184
AKEBIA THERAPEUTICS INC
$170
Coala Life Inc
$153
Fresenius USA Marketing, Inc.
$141
Lilly USA, LLC
$137
NxStage Medical, Inc.
$132
CALLIDITAS THERAPEUTICS US INC.
$119
Genentech USA, Inc.
$100
Merck Sharp & Dohme LLC
$95
Calliditas Therapeutics US Inc.
$81
Outset Medical Inc
$78
Ardelyx, Inc.
$74
Takeda Pharmaceuticals U.S.A., Inc.
$68
Shire North American Group Inc
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
GENZYME CORPORATION
$48
Alexion Pharmaceuticals, Inc.
$36
ABIOMED
$32
Retrophin, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$16
West-Ward Pharmaceuticals
$16
Horizon Pharma plc
$14
CorMedix Inc.
$14
Nestle HealthCare Nutrition Inc.
$13
Top 3 companies account for 63.4% of total payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · AFINITOR · Auryxia · BENLYSTA · Coala Heart Monitor · Corlanor · DefenCath · ENTRESTO · EVUSHELD · FABRAZYME · FABRY-DISEASE · FARXIGA · Fabhalta · GATTEX · GIVLAARI · IBSRELA · INJECTAFER · Impella · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LEQVIO · LOKELMA · LUPKYNIS · Mitigare · NXSTAGE SYSTEM ONE · Non-Franchise (NOF) - NonProduct · OFIRMEV · ONPATTRO · OXLUMO · PRALUENT · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · Renal - Acute · Renal - CRRT · Renal - Chronic · Renal - HD · Renal - PD · Renal - Prismaflex System · Repatha · Rituxan · SAMSCA · TARPEYO · TAVNEOS · TERLIVAZ · Tavneos · Thiola · ULTOMIRIS · Uloric · Ultomiris · VERQUVO · Velphoro · Veltassa · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for nephrology in FL.

Equivalent to $2,624 per 100 Medicare services performed
Looking for a nephrology in Naples?
Compare nephrologys in the Naples area by procedure volume, costs, and industry payment transparency.
Browse nephrologys nearby

Geographic Context

Nephrologys within 10 mi
28
Per 100K population
7.2
County median income
$86,173
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
5.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Russo is a clinical cardiology specialist, with above-average Medicare volume (top 18% in FL), and high industry engagement (speaking/promotional, top 3%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Russo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Russo performed 972 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Russo receive payments from pharmaceutical companies?
Yes. Dr. Russo received a total of $75,386 from 45 companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Russo's costs compare to other nephrologys in Naples?
Dr. Russo's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Russo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →